Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
91 Cards in this Set
- Front
- Back
Absence seizures
|
Ethosuximide
|
|
Acute gout attack
|
NSAIDs, colchicine
|
|
Acute promyelocytic leukemia (M3)
|
All-trans retinoic acid
|
|
ADHD
|
Methylphenidate, amphetamines
|
|
Alcohol abuse
|
AA + disulfiram for patient and Al-Anon for family
|
|
Alcohol withdrawal
|
Benzodiazepines
|
|
Anorexia
|
SSRIs
|
|
Anticoagulation during pregnancy
|
Heparin
|
|
Anxiety
|
Buspirone
Nb. Generalized anxiety disorder (no other indications) |
|
Arrythmia in damaged cardiac tissue
|
Class IB antiarrythmic (lidocaine, mexiletine, tocainide)
|
|
B12 deficiency
|
B12
|
|
Benign prostatic hyperplasia
|
Tamsulosin, finasteride
|
|
Bipolar disorder
|
Lithium, valproate, carbamazepine (mood stabilizers)
|
|
Breast cancer in postmenopausal woman
|
Aromatase inhibitor
|
|
Buerger's disease
|
Smoking cessation
|
|
Bulimia
|
SSRIs
|
|
Candida albicans
|
Amphotericin B (systemic), nystatin (oral thrush, esophagitis)
|
|
Carcinoid syndrome
|
Octreotide
Nb. Somatostatin analog |
|
Chlamydia trachomatis
|
Doxycycline (+ ceftriaxone for gonorrhea coinfection), erythromycin eye drops (prophylaxis in infants)
|
|
Chronic gout
|
Probenicid (underexcretor), allopurinol (overproducer)
|
|
Chronic hepatitis
|
IFN-α
|
|
Chronic myelogenous leukemia
|
Imatinib
|
|
Clostridium botulinum
|
Antitoxin
|
|
Clostridium difficile
|
Oral metronidazole
|
|
Clostridium tetani
|
Antitoxin + vaccine booster + diazepam
|
|
Crohn's disease
|
Corticosteroids, infliximab
Nb. infliximab = anti-TNF-α |
|
Cryptococcus neoformans
|
Fluconazole (prophylaxis in AIDS patients)
|
|
Cystic fibrosis
|
N-acetylcysteine + antipseudomonal prophylaxis (tobramycin/azithromycin)
|
|
Cytomegalovirus
|
Ganciclovir
|
|
Depression
|
SSRIs (first-line)
|
|
Diabetes insipidus
|
Desmopressin (central); hydrochlorothiazide, indomethacin, amiloride (nephrogenic)
|
|
Diabetes mellitus type 1
|
Dietary intervention (low-sugar) + insulin replacement
|
|
Diabetes mellitus type 2
|
Dietary intervention, oral hypoglycemic, and insulin (possible)
|
|
Diabetic ketoacidosis
|
Fluids, insulin, K+
|
|
Enterococci
|
Vancomycin/ampicillin + aminoglycoside
|
|
Erectile dysfunction
|
Sildenafil
|
|
ER-positive breast cancer
|
Tamoxifen
|
|
Ethylene glycol/methanol intoxication
|
Fomepizole (alcohol dehydrogenase inhibitor)
|
|
Folate deficiency
|
Folate
|
|
Haemophilus influenzae (B)
|
Rifampin (prophylaxis)
|
|
Hemorrhagic cystitis
|
Mesna
|
|
Heparin toxicity (acute)
|
Protamine sulfate
|
|
HER2/neu-positive breast cancer
|
Trastuzumab
|
|
Hyperaldosteronism
|
Spironolactone
|
|
Hypercholesterolemia
|
Statin (first-line)
|
|
Hypertriglyceridemia
|
Fibrate
|
|
Immediate anticoagulation
|
Heparin
|
|
Infertility
|
Leuprolide, GnRH (pulsatile)
Nb. leuprolide = GnRH analog |
|
Influenza
|
Amantadine/rimantadine
|
|
Legionella pneumophila
|
Erythromycin
|
|
Long-term anticoagulation
|
Warfarin
|
|
Malaria
|
Chloroquine/mefloquine (for blood schizont), primaquine (for liver hypnozoite)
|
|
Malignant hyperthermia
|
Dantrolene
|
|
Medical abortion
|
Mifepristone
Nb. progesterone receptor antagonist |
|
Migraine
|
Sumatriptan
Nb. Serotonin agonist |
|
MRSA
|
Vancomycin
|
|
Multiple sclerosis
|
β-interferon
|
|
Mycobacterium tuberculosis
|
RIPES (rifampin, INH, pyrazinamide, ethambutol, streptomycin)
|
|
Neisseria gonorrheae
|
Ceftriaxone (add doxycycline to cover likely concurrent Chlamydia)
|
|
Neisseria meningitidis
|
Penicillin/ceftriaxone, rifampin (prophylaxis)
|
|
Neural tube defect prevention
|
Folate
|
|
Osteomalacia/rickets
|
Vitamin D supplementation
|
|
Patent ductus arteriosus
|
Indomethacin
Nb. an NSAID |
|
Pheochromocytoma
|
α-antagonists
|
|
Pneumocystis jiroveci
|
TMP-SMX (prophylaxis in AIDS patient)
|
|
Prolactinoma
|
Bromocriptine (dopamine agonists)
|
|
Prostate cancer/uterine fibroids
|
Leuprolide, GnRH (continous)
|
|
Prostate carcinoma
|
Flutamide
|
|
Pseudomonas aeruginosa
|
Antipseudomonal penicillin + aminoglycoside
|
|
Pulmonary hypertension
|
Bosentan
Nb. an endothelin receptor antagonist |
|
Rickettsia rickettsii
|
Tetracycline, chloramphenicol (especially in context of aplastic anemia)
|
|
Ringworm infections
|
Terbinafine, griseofulvin, imidazole
|
|
Schizophrenia (negative symptoms)
|
5-HT(2A) antagonists (e.g., olanzapine)
|
|
Schizophrenia (positive symptoms)
|
D2 receptor antagonists
|
|
SIADH
|
Demeclocycline, lithium
|
|
Sickle cell anemia
|
Hydroxyurea (incr HbF)
|
|
Sporothrix schenckii
|
Oral KI
|
|
Stable angina
|
Sublingual nitroglycerin
|
|
Staphylococcus aureus
|
Methicillin/naficillin
|
|
Streptococcus bovis
|
Penicillin prophylaxis
|
|
Streptococcus pneumoniae
|
Penicillin/cephalosporin (systemic infection, pneumonia), vancomycin (meningitis)
|
|
Streptococcus pyogenes
|
Penicillin prophylaxis
|
|
Temporal arteritis
|
High-dose steroids
|
|
Tonic-clonic seizures
|
Phenytoin, valproate, carbamazepine
|
|
Toxoplasma gondii
|
Sulfonamide + pyrimethamine
|
|
Treponema pallidum
|
Penicillin
|
|
Trichomonas vaginalis
|
Metronidazole (patient and partner)
|
|
Ulcerative colitis
|
5-ASA, infliximab
Nb. 5-ASA = anti-COX/LiPOX, infliximab = anti-TNF-α |
|
UTI prophylaxis
|
TMP-SMX
|
|
Warfarin toxicity
|
Fresh frozen plasma (acute), vitamin K (chronic)
|
|
Wegener's granulomatosis
|
Cyclophosphamide, corticosteroids
|